Five things to know about: Mixing and matching coronavirus vaccines

Amid global vaccine rollouts, with nearly 1.2 billion doses currently administered, some countries have recommended a mixed-dose approach where a first prime shot is followed by a booster of a second type.  The measure has been introduced by France and Germany for people who received a first dose of the AstraZeneca vaccine but are in age groups for which that vaccine is … Read more

Q&A: BioNTech vaccine is only ‘mRNA 1.0’. This is just the beginning, say co-founders

The successful development of mRNA vaccines for Covid-19 is ‘transformational’ and opens the doors to new types of vaccines for other infectious diseases as well as cancer, according to Dr Özlem Türeci and Dr Uğur Şahin, the co-founders of Germany’s BioNTech. The main question, they say, is which vaccine to prioritise first. The Pfizer/BioNTech coronavirus vaccine was … Read more